Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara M McGowan

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Obesity Facts|June 5, 2016
A Practical Guide to Engaging Individuals with ObesityBarbara M McGowan
European Journal of Internal Medicine|June 19, 2024
Pharmacotherapy for older people with obesityLuke D Boyle, Feray Akbas, Dilek Yazıcı, et al.
Italian Journal of Anatomy and Embryology = Archivio Italiano Di Anatomia Ed Embriologia|March 20, 2014
Plasma insulin-like factor 3 (INSL3) in male patients with osteoporosis and Klinefelter's syndromeAndleeb Hussain, Ramasamyiyer Swaminathan, Arun Sankaralingam, et al.
Obesity (Silver Spring, Md.)|March 6, 2023
Impact of BMI and comorbidities on efficacy of once-weekly semaglutide: Post hoc analyses of the STEP 1 randomized trialBarbara M McGowan, Azadeh Houshmand-Oeregaard, Peter Nørkjaer Laursen, et al.
Clinical Case Reports|October 14, 2017
Making (mis) sense of asymptomatic marked hypercalcemia in pregnancyGiuseppe Maltese, Louise Izatt, Barbara M McGowan, et al.
BMJ Open|July 1, 2021
Changing the narrative around obesity in the UK: a survey of people with obesity and healthcare professionals from the ACTION-IO studyCarly A Hughes, Amy L Ahern, Harsha Kasetty, et al.
Obesity Science & Practice|February 12, 2024
Real-world data of a digitally enabled, time-restricted eating weight management program in public sector workers living with overweight and obesity in the United Kingdom: A service evaluation of the Roczen programAdrian Brown, Laurence J Dobbie, Laura Falvey, et al.
The Lancet. Diabetes & Endocrinology|August 1, 2024
Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trialBarbara M McGowan, Jens M Bruun, Matt Capehorn, et al.
Clinical Obesity|September 11, 2025
Variation in the Commissioning of Semaglutide for the Treatment of Obesity and Overweight Across England: Results of Three Freedom of Information-Based Mapping Exercises Across the 42 Integrated Care Boards of EnglandAnne de Bray, Hanna Schnitzer, Elisabeth Mahase, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2005
Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human malesWaljit S Dhillo, Owais B Chaudhri, Michael Patterson, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Obesity Facts|June 5, 2016
A Practical Guide to Engaging Individuals with ObesityBarbara M McGowan
European Journal of Internal Medicine|June 19, 2024
Pharmacotherapy for older people with obesityLuke D Boyle, Feray Akbas, Dilek Yazıcı, et al.
Italian Journal of Anatomy and Embryology = Archivio Italiano Di Anatomia Ed Embriologia|March 20, 2014
Plasma insulin-like factor 3 (INSL3) in male patients with osteoporosis and Klinefelter's syndromeAndleeb Hussain, Ramasamyiyer Swaminathan, Arun Sankaralingam, et al.
Obesity (Silver Spring, Md.)|March 6, 2023
Impact of BMI and comorbidities on efficacy of once-weekly semaglutide: Post hoc analyses of the STEP 1 randomized trialBarbara M McGowan, Azadeh Houshmand-Oeregaard, Peter Nørkjaer Laursen, et al.
Clinical Case Reports|October 14, 2017
Making (mis) sense of asymptomatic marked hypercalcemia in pregnancyGiuseppe Maltese, Louise Izatt, Barbara M McGowan, et al.
BMJ Open|July 1, 2021
Changing the narrative around obesity in the UK: a survey of people with obesity and healthcare professionals from the ACTION-IO studyCarly A Hughes, Amy L Ahern, Harsha Kasetty, et al.
Obesity Science & Practice|February 12, 2024
Real-world data of a digitally enabled, time-restricted eating weight management program in public sector workers living with overweight and obesity in the United Kingdom: A service evaluation of the Roczen programAdrian Brown, Laurence J Dobbie, Laura Falvey, et al.
The Lancet. Diabetes & Endocrinology|August 1, 2024
Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trialBarbara M McGowan, Jens M Bruun, Matt Capehorn, et al.
Clinical Obesity|September 11, 2025
Variation in the Commissioning of Semaglutide for the Treatment of Obesity and Overweight Across England: Results of Three Freedom of Information-Based Mapping Exercises Across the 42 Integrated Care Boards of EnglandAnne de Bray, Hanna Schnitzer, Elisabeth Mahase, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2005
Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human malesWaljit S Dhillo, Owais B Chaudhri, Michael Patterson, et al.
Pageof 2